• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MLXIPL 通过磷酸化 mTOR 促进肝癌细胞的迁移、侵袭和糖酵解。

MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR.

机构信息

Department of General Surgery, The First Affiliated Hospital of Xi'an Medical University, No. 48, Fenghao West Road, Lianhu District, 710077, Xi'an, Shaanxi, China.

Department of Clinical Laboratory, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.

出版信息

BMC Cancer. 2023 Feb 21;23(1):176. doi: 10.1186/s12885-023-10652-5.

DOI:10.1186/s12885-023-10652-5
PMID:36809979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9945719/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is associated with a high occurrence, mortality, and poor prognosis. MLX interacting protein like (MLXIPL) is an important regulator of glucolipid metabolism and is involved in tumor progression. We aimed to clarify the role of MLXIPL in HCC and its underlying mechanisms.

METHODS

The level of MLXIPL was predicted using bioinformatic analysis and verified using quantitative real-time PCR (qPCR), immunohistochemical analysis, and western blot. We assessed the effects of MLXIPL on biological behaviors using the cell counting kit-8, colony formation, and Transwell assay. Glycolysis was evaluated using the Seahorse method. The interaction between MLXIPL and mechanistic target of rapamycin kinase (mTOR) was confirmed using RNA immunoprecipitation and co-immunoprecipitation. mTOR expression was detected in HCC cells using qPCR, immunofluorescence analysis, and western blot.

RESULTS

The results showed that MLXIPL levels were elevated in both HCC tissues and HCC cell lines. Knockdown of MLXIPL impeded HCC cell growth, invasion, migration, and glycolysis. Moreover, MLXIPL combined with mTOR to induce phosphorylation of mTOR. Activated mTOR abrogated the effects on cellular processes induced by MLXIPL.

CONCLUSION

MLXIPL promoted the malignant progression of HCC by activating phosphorylation of mTOR, suggesting an important role of the combination of MLXIPL and mTOR in HCC.

摘要

背景

肝细胞癌(HCC)的发病率、死亡率和预后均较差。MLX 相互作用蛋白样(MLXIPL)是糖脂代谢的重要调节因子,参与肿瘤进展。本研究旨在阐明 MLXIPL 在 HCC 中的作用及其潜在机制。

方法

采用生物信息学分析预测 MLXIPL 水平,并通过定量实时 PCR(qPCR)、免疫组织化学分析和 Western blot 进行验证。我们通过细胞计数试剂盒-8、集落形成和 Transwell 检测评估 MLXIPL 对细胞生物学行为的影响。通过 Seahorse 法评估糖酵解。采用 RNA 免疫沉淀和免疫共沉淀验证 MLXIPL 与雷帕霉素靶蛋白激酶(mTOR)之间的相互作用。采用 qPCR、免疫荧光分析和 Western blot 检测 HCC 细胞中 mTOR 的表达。

结果

结果表明,MLXIPL 水平在 HCC 组织和 HCC 细胞系中均升高。敲低 MLXIPL 可抑制 HCC 细胞的生长、侵袭、迁移和糖酵解。此外,MLXIPL 与 mTOR 结合诱导 mTOR 的磷酸化。激活的 mTOR 可阻断 MLXIPL 诱导的细胞过程的作用。

结论

MLXIPL 通过激活 mTOR 的磷酸化促进 HCC 的恶性进展,表明 MLXIPL 和 mTOR 的结合在 HCC 中具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/a18e3f7778e2/12885_2023_10652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/3847b7962498/12885_2023_10652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/5a978726e0a6/12885_2023_10652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/43682df995a7/12885_2023_10652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/a18e3f7778e2/12885_2023_10652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/3847b7962498/12885_2023_10652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/5a978726e0a6/12885_2023_10652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/43682df995a7/12885_2023_10652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c572/9945719/a18e3f7778e2/12885_2023_10652_Fig4_HTML.jpg

相似文献

1
MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR.MLXIPL 通过磷酸化 mTOR 促进肝癌细胞的迁移、侵袭和糖酵解。
BMC Cancer. 2023 Feb 21;23(1):176. doi: 10.1186/s12885-023-10652-5.
2
UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.UBE2O 通过调控 AMPKα2/mTOR 通路促进肝癌细胞的增殖和侵袭。
Int J Med Sci. 2021 Oct 11;18(16):3749-3758. doi: 10.7150/ijms.63220. eCollection 2021.
3
mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.mTOR 通过 NEAT1 和核斑点介导的机制调节肝癌中的有氧糖酵解。
Theranostics. 2022 Apr 24;12(7):3518-3533. doi: 10.7150/thno.72581. eCollection 2022.
4
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.MYO18B通过激活PI3K/AKT/mTOR信号通路促进肝细胞癌进展。
Diagn Pathol. 2018 Nov 3;13(1):85. doi: 10.1186/s13000-018-0763-3.
5
CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.CDCA2 通过 AKT-mTOR 通路促进 HCC 细胞的发展。
Anal Cell Pathol (Amst). 2022 Dec 22;2022:9912254. doi: 10.1155/2022/9912254. eCollection 2022.
6
Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.双功能酶ATIC 通过调节 AMPK-mTOR-S6K1 信号通路促进肝癌的增殖。
Cell Commun Signal. 2017 Dec 16;15(1):52. doi: 10.1186/s12964-017-0208-8.
7
Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.线粒体核糖体蛋白 L12 通过调节线粒体生物发生和代谢重编程促进肝细胞癌的发生。
Metabolism. 2024 Mar;152:155761. doi: 10.1016/j.metabol.2023.155761. Epub 2023 Dec 15.
8
[P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].[脯氨酰-4-羟化酶2通过调节PI3K/Akt/mTOR信号通路促进肝癌的发生和发展]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):665-672. doi: 10.12122/j.issn.1673-4254.2022.05.06.
9
circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway.circACTG1 通过调控 miR-940/RIF1 轴和激活 AKT/mTOR 通路促进肝癌进展。
J Immunol Res. 2022 Jun 19;2022:8649386. doi: 10.1155/2022/8649386. eCollection 2022.
10
Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.转录因子特异性蛋白 1 介导丝氨酸/苏氨酸激酶 39 的上调通过激活转化生长因子-β1/Smad2/3 通路促进肝癌细胞的增殖、迁移、侵袭和上皮-间充质转化。
Bioengineered. 2021 Dec;12(1):3566-3577. doi: 10.1080/21655979.2021.1947939.

引用本文的文献

1
Carbohydrate-Responsive Element-Binding Protein-Associated Metabolic Changes in Chemically Induced Hepatocarcinogenesis Mouse Model.化学诱导肝癌发生小鼠模型中碳水化合物反应元件结合蛋白相关的代谢变化
Int J Mol Sci. 2025 Jul 18;26(14):6932. doi: 10.3390/ijms26146932.
2
ScRNA-seq combined with ATAC-seq analysis to explore the metabolic balance mechanism of CCl4-induced liver inflammatory injury.单细胞RNA测序联合染色质转座酶可及性测序分析以探究四氯化碳诱导的肝脏炎性损伤的代谢平衡机制。
Front Immunol. 2025 Jun 16;16:1600685. doi: 10.3389/fimmu.2025.1600685. eCollection 2025.
3
Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia.

本文引用的文献

1
Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights.抗肝癌生物分子:分子靶点洞察。
Int J Mol Sci. 2021 Oct 6;22(19):10774. doi: 10.3390/ijms221910774.
2
From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies.从 OCR 和 ECAR 到能量:生物能量学研究设计和解释的观点。
J Biol Chem. 2021 Oct;297(4):101140. doi: 10.1016/j.jbc.2021.101140. Epub 2021 Aug 28.
3
Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.ChREBP在肝脏和胰岛中的适应性和适应不良作用。
由于 R213G 多态性导致 SOD3 表达重新分布,从而影响低氧环境下肺间质巨噬细胞的重编程。
Physiol Genomics. 2024 Nov 1;56(11):776-790. doi: 10.1152/physiolgenomics.00078.2024. Epub 2024 Sep 23.
4
GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing.糖化白蛋白和 C 反应蛋白具有遗传相关性:炎症衰老遗传结构的新见解。
Biomolecules. 2024 May 8;14(5):563. doi: 10.3390/biom14050563.
5
LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA.长链非编码RNA HOTAIR通过招募丝氨酸/精氨酸丰富剪接因子1(SRSF1)来稳定己糖激酶同工酶IV(MLXIPL)信使核糖核酸,从而加速游离脂肪酸诱导的HepG2细胞炎症反应。
Cytotechnology. 2024 Apr;76(2):259-269. doi: 10.1007/s10616-023-00614-x. Epub 2024 Feb 20.
6
Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis.糖酵解标志物与肝癌预后的关系:系统评价和荟萃分析。
World J Surg Oncol. 2023 Dec 20;21(1):390. doi: 10.1186/s12957-023-03275-4.
7
Cannflavins A and B with Anti-Ferroptosis, Anti-Glycation, and Antioxidant Activities Protect Human Keratinocytes in a Cell Death Model with Erastin and Reactive Carbonyl Species.具有抗铁死亡、抗糖化和抗氧化活性的 Cannflavins A 和 B 通过 Erastin 和活性羰基物种保护人角质形成细胞免于细胞死亡模型。
Nutrients. 2023 Oct 27;15(21):4565. doi: 10.3390/nu15214565.
J Biol Chem. 2021 Jan-Jun;296:100623. doi: 10.1016/j.jbc.2021.100623. Epub 2021 Apr 2.
4
Single-cell analysis reveals the intra-tumor heterogeneity and identifies MLXIPL as a biomarker in the cellular trajectory of hepatocellular carcinoma.单细胞分析揭示了肿瘤内异质性,并将MLXIPL鉴定为肝细胞癌细胞轨迹中的生物标志物。
Cell Death Discov. 2021 Jan 18;7(1):14. doi: 10.1038/s41420-021-00403-5.
5
ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.ACSS3 通过下调脂滴相关蛋白 PLIN3 抑制前列腺癌进展。
Theranostics. 2021 Jan 1;11(2):841-860. doi: 10.7150/thno.49384. eCollection 2021.
6
Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.肝细胞癌:解析形态异质性、生长模式和亚型。
Hum Pathol. 2021 Jun;112:86-101. doi: 10.1016/j.humpath.2020.12.009. Epub 2020 Dec 30.
7
Exosomal circFBLIM1 Promotes Hepatocellular Carcinoma Progression and Glycolysis by Regulating the miR-338/LRP6 Axis.外泌体circFBLIM1通过调控miR-338/LRP6轴促进肝细胞癌进展和糖酵解
Cancer Biother Radiopharm. 2023 Dec;38(10):674-683. doi: 10.1089/cbr.2020.3564. Epub 2020 Sep 9.
8
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.有氧糖酵解在肝细胞癌中的新兴作用和调控。
J Exp Clin Cancer Res. 2020 Jul 6;39(1):126. doi: 10.1186/s13046-020-01629-4.
9
SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway.SLFN11 通过靶向 mTOR 通路抑制 RPS4X 抑制肝癌的发生和转移。
Theranostics. 2020 Mar 25;10(10):4627-4643. doi: 10.7150/thno.42869. eCollection 2020.
10
Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation.碳水化合物反应元件结合蛋白 (ChREBP) 与结肠癌的进展相关,并促进细胞增殖。
Sci Rep. 2020 Mar 6;10(1):4233. doi: 10.1038/s41598-020-60903-9.